Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,044.29 +25.90 (+0.52%) Dow
38,118.21 +214.92 (+0.57%) Nasdaq
15,743.63 +138.15 (+0.89%) Bitcoin USD
59,206.38 +2,121.00 (+3.72%) CMC Crypto 200
1,272.90 +2.16 (+0.17%)
DiaMedica Therapeutics Inc. (DMAC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:35AM EDT. Market open.
| Previous close | 2.5900 |
| Open | 2.6000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.5752 - 2.6000 |
| 52-week range | 1.5800 - 4.7500 |
| Volume | |
| Avg. volume | 37,572 |
| Market cap | 98.691M |
| Beta (5Y monthly) | 1.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Bullish DiaMedica Therapeutics Insiders Loaded Up On US$15.7m Of Stock
Multiple insiders secured a larger position in DiaMedica Therapeutics Inc. ( NASDAQ:DMAC ) shares over the last 12...
- Zacks
DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
DiaMedica (DMAC) rises 10% as it doses the first patient in the relaunch of its pivotal study evaluating the lead candidate, DM199, to treat acute ischemic stroke.
- Zacks
DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
DiaMedica Therapeutics (DMAC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
© 2024 Yahoo. All rights reserved.